| Laboratory: | Clinical Biochemistry | ||||
| Test Name: |
BETA-2-MICROGLOBULIN - (P)
Test Code:
BZMG
|
||||
| Clinical Information: |
Test performed at: Health Sciences Centre
This test is used for prognosis assessment of multiple myeloma. Beta-2-microglobulin is a small membrane protein similar to the major histocompatibility complex proteins. It's small size allows rapid filtration through renal glomeruli and subsequent reabsorbtion in the proximal tubules. Beta-2-microglobulin levels are increased in diseases associated with increased cell turnover. It is also elevated in autoimmune diseases, inflammation, liver disease, neoplasms and malignancies such as myeloma. |
||||
| Collection Devices: |
Collect a minimum of 0.5 mL pediatric blood in each microtainer.
|
||||
| Specimen Required: |
Plasma: 2.0 mL
Pediatric Plasma: 0.3 mL
Stability 3 days refrigerated, 6 months frozen |
||||
| Referral: |
Serum: 2.0 mL
Samples must be transferred to an aliquot tube and stored frozen if analysis will not be complete within 48 hours (#110-10-05 Serum / Plasma Separation Procedure & Transport)
|
||||
| Requisition: | |||||
| Reference Values: |
1.1 - 2.4 mg/L (mg/L x 84.7 = nmol/L)
|
||||
| Availability: |
Daily
|
||||
| See Also: | |||||
| More Information: |